Identifying and validating suitable drug targets is crucial for the success of drug discovery. While researchers have identified numerous proteins, they have successfully utilized only a small fraction as drug targets. The emergence of targeted protein degradation technologies offers a promising approach to address this challenge. By allowing researchers to target previously undruggable proteins, these technologies open the door to novel therapies for a wide range of diseases.
Download this whitepaper from Excelra to learn how to identify and prioritize the most promising druggable targets for drug discovery.
